Dutch-based Alveron Pharma raises €5M to advance therapy for intracranial haemorrhage
Nijmegen, The Netherlands-based Alveron Pharma, a clinical-stage company, announced on Monday that it has secured €5M in a Series Seed extension funding round led by Broadview Ventures.